ARTICLE | Company News
Biogen Idec, Eli Lilly, GlaxoSmithKline, J&J, Pfizer, Alzheimer’s Research UK, U.K. Department of Health neurology news
March 23, 2015 7:00 AM UTC
The U.K. government unveiled its $100 million Dementia Discovery Fund to support dementia research. GlaxoSmithKline invested $25 million, while Johnson & Johnson invested $10 million through its venture arm, Johnson & Johnson Innovation-JJDC Inc. Other investors include Biogen Idec, Eli Lilly, Pfizer, Alzheimer’s Research UK and the U.K. government. The fund is expected to operate like a typical venture capital fund. Proceeds from licensing or sale of programs in which it invests will be returned to the fund and its investors. ...